The vaccines division of sanofi aventis group. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the ...
Hosted on MSN2mon
Sanofi's 21-Valent Pneumococcal Vaccine Enters Phase IIIYear to date, shares of Sanofi have lost 4% against the industry’s growth of 1.4%. Image Source: Zacks Investment Research Per the expanded collaboration agreement, Sanofi and SK bioscience will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback